Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Pharmaceuticals, Biotechnology and Life Sciences
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…
Preclinical models show benefit of afamelanotide as MC1R therapy in Parkinson’s DiseaseMELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) — CLINUVEL…
PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…
MIAMI, FL, June 17, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on…
DALLAS, June 17, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical…
Drug Information Association (DIA) 2024 is the largest global, multidisciplinary event for the professionals involved in the discovery, development, and…